In the past 4 years Neuren has produced its annual report between late March and late April. So we are in the window to expect some more detail in the next few weeks.
I am hoping they are trying to finalise the deal ahead of this or at least get some indication on what the P3 funding arrangements will likely be. Surely someone wants in!
- Forums
- ASX - By Stock
- NEU
- Ann: Disclosure under Listing Rule 4.3D
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.55%
!
$16.52
Ann: Disclosure under Listing Rule 4.3D, page-59
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
